# Efficacy and Safety of Risperidone Oral Solution Combination Clonazepam Versus Haloperidol Intramuscular (IM) Injection for Treatment of Acute Psychotic Agitation in Schizophrenia

> **NCT00859872** · PHASE4 · COMPLETED · sponsor: **Central South University** · enrollment: 198 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** risperidone oral solution
- **DRUG:** haloperidol

## Key facts

- **NCT ID:** NCT00859872
- **Lead sponsor:** Central South University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 198 (ACTUAL)
- **Last updated:** 2009-08-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00859872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00859872, "Efficacy and Safety of Risperidone Oral Solution Combination Clonazepam Versus Haloperidol Intramuscular (IM) Injection for Treatment of Acute Psychotic Agitation in Schizophrenia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00859872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*